【摘 要】
：
Most attempts at rational development of new analgesics have failed,in part because chronic pain involves multiple processes that remain poorly understood.To improve translational success,one strategy is to select novel targets for which there is proof of
【机 构】
：
Kirby Neurobiology Center,Boston Children’s Hospital and Department of Neurobiology,Harvard Medical
论文部分内容阅读
Most attempts at rational development of new analgesics have failed,in part because chronic pain involves multiple processes that remain poorly understood.To improve translational success,one strategy is to select novel targets for which there is proof of clinical relevance,either genetically through heritable traits,or pharmacologically.Such an approach by definition yields targets with high clinical validity.The biology of these targets can be elucidated in animal models before returning to the patients with a refined therapeutic.For optimal treatment,having biomarkers of drug action available is also a plus.Here we describe a case study in rational drug design:the use of controlled inhibition of peripheral tetrahydrobiopterin (BH4) synthesis to reduce abnormal chronic pain states without altering nociceptive-protective pain.Initially identified in a population of patients with low back pain,the association between BH4 production and chronic pain has been confirmed in more than 12 independent cohorts,through a common haplotype (present in 25％ of Caucasians) of the rate-limiting enzyme for BH4 synthesis,GTP cyclohydrolase 1 (GCH1).Genetic tools in mice have demonstrated that both injured sensory neurons and activated macrophages engage increased BH4 synthesis to cause chronic pain.GCH1 is an obligate enzyme for de novo BH4 production.Therefore,inhibiting GCH1 activity eliminates all BH4 production,affecting the synthesis of multiple neurotransmitters and signaling molecules and interfering with physiological function.In contrast,targeting the last enzyme of the BH4 synthesis pathway,sepiapterin reductase (SPR),allows reduction of pathological BH4 production without completely blocking physiological BH4 synthesis.Systemic SPR inhibition in mice has not revealed any safety concerns to date,and available genetic and pharmacologic data suggest similar responses in humans.Finally,because it is present in vivo only when SPR is inhibited,sepiapterin serves as a reliable biomarker of target engagement,allowing potential quantification of drug efficacy.The emerging development of therapeutics that target BH4 synthesis to treat chronic pain illustrates the power of combining human and mouse genetics:human genetic studies for clinical selection of relevant targets,coupled with causality studies in mice,allowing the rational engineering of new analgesics.
其他文献
The reported prevalence of autism spectrum disorder (ASD) has been increasing rapidly in many parts of the world.However,data on its prevalence in China are largely missing.Here,we assessed the suitability of the modified Chinese version of a newly-develo
Our previous studies proposed that Alzheimer\'s disease (AD) is a metabolic disorder and hypothesized that abnormal brain glucose metabolism inducing multiple pathophysiological cascades contributes to AD pathogenesis.Aging is one of the great significa
Observations from clinical trials have frequently demonstrated that light therapy can be an effective therapy for seasonal and non-seasonal major depression.Despite the fact that light therapy is known to have several advantages over antidepressant drugs
Pain and itch are unpleasant sensations that often accompany infections caused by viral,bacterial,parasitic,and fungal pathogens.Recent studies show that sensory neurons are able to directly detect pathogens to mediate pain and itch.Nociceptor and prurice
Parkinson\'s disease (PD) is recognized as the second most common neurodegenerative disorder after Alzheimer disease.Although a fascinating 200-year journey of research has revealed the multifaceted nature of PD [1,2],its fundamental features are the lo
Nociception is an important physiological process that detects harmful signals and results in pain perception.In this review,we discuss important experimental evidence involving some TRP ion channels as molecular sensors of chemical,thermal,and mechanical
Memory is a crucial biological function conserved across almost all organisms.Once established and consolidated,a memory is considered stable and long-lasting unless it is disrupted or manipulated by behavioral,physical,or chemical interventions.Behaviora
Human functional MRI studies in acute and various chronic pain conditions have revolutionized how we view pain,and have led to a new theory that complex multi-dimensional pain experience (sensory-discriminative,affective/motivational,and cognitive) is rep
Chronic pain and itch are a pathological operation of the somatosensory system at the levels of primary sensory neurons,spinal cord and brain.Pain and itch are clearly distinct sensations,and recent studies have revealed the separate neuronal pathways tha
In 1905,Henry Head first suggested that transmission of pain-related protopathic information can be negatively modulated by inputs from afferents sensing innocuous touch and temperature.In 1965,Melzak and Wall proposed a more concrete gate control theory